Usana Health Sciences Q2 2024 GAAP EPS $0.54 Misses $0.65 Estimate, Sales $212.869M Miss $221.032M Estimate
Portfolio Pulse from Benzinga Newsdesk
Usana Health Sciences (NYSE:USNA) reported Q2 2024 earnings per share of $0.54, missing the analyst estimate of $0.65 by 16.92%. The company also reported sales of $212.869 million, which missed the estimate of $221.032 million by 3.69%. This represents a 10.64% decrease from the same period last year.
July 23, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Usana Health Sciences reported Q2 2024 earnings and sales that missed analyst estimates. EPS was $0.54, below the $0.65 estimate, and sales were $212.869 million, below the $221.032 million estimate. This also marks a 10.64% decrease in sales from the same period last year.
The significant miss on both EPS and sales estimates, along with a notable year-over-year decline in sales, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100